Sonal Adhesives Limited will convene a board meeting on May 28, 2026, to approve its audited financial results for the fourth quarter and the full fiscal year ending March 31, 2026. In conjunction with this, the company has declared a trading window closure for designated persons and insiders from April 1 to May 30, 2026, a standard practice to prevent insider trading.
While the company reported revenues of ₹111.67 Cr and a net profit of ₹2 Cr for fiscal year 2025, recent performance has shown a mixed trend. In Q3 FY26 (ended December 31, 2025), revenue grew 9.77% year-on-year to ₹29.33 Cr, but net profit saw a significant decline of 50% year-on-year to ₹0.15 Cr.
Profitability indicators have been under pressure. The company's Return on Capital Employed (ROCE) stood at 14.74% for the half-year period, its lowest in recent times. Quarterly Earnings Per Share (EPS) also hit a low of Rs.0.25 in Q3 FY26, contributing to investor concerns.
The audited financial results for FY26 will provide a comprehensive, year-end view of the company's financial health. Shareholders and investors rely on these figures for informed decision-making.
Investors are closely watching the audited FY26 results for signs of sustained profitability improvement. The significant net profit decline in Q3 FY26, coupled with the low quarterly EPS and the company's stock hitting a 52-week low in early March 2026, highlights these concerns. The stock has also underperformed broader market indices like the Sensex and BSE500 over the past year.
Moving forward, the primary focus will be on the announcement of Sonal Adhesives' audited financial results for Q4 and FY26. Investors will scrutinize revenue growth, profit margins, and key financial ratios to assess the company's performance and turnaround potential. Monitoring management commentary will be crucial for understanding future strategies.
